MoneyWorks4Me

Lactose India - Quaterly Results

12 Feb 2025 Evaluate
The sales for the December 2024 quarter moved down to Rs. 287.19 millions as compared to Rs. 325.99 millions during the year-ago period.Net Profit for the quarter ended December 2024 dipped to Rs. 2.20  millions from Rs. 26.29 millions  in the corresponding previous quarter.A decline of 35.26 millions was observed in the OP in the quarter ended December 2024 from 60.06 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 287.19 325.99 -11.90 886.29 844.92 4.90 1138.90 657.96 73.10
Other Income 5.62 2.81 100.00 10.83 8.20 32.07 11.25 7.19 56.47
PBIDT 35.26 60.06 -41.29 146.31 137.09 6.73 201.23 120.98 66.33
Interest 16.37 12.14 34.84 42.65 40.80 4.53 52.40 59.48 -11.90
PBDT 18.89 47.92 -60.58 103.66 96.29 7.65 148.83 61.50 142.00
Depreciation 13.54 11.97 13.12 39.97 35.86 11.46 52.19 46.85 11.40
PBT 5.35 35.95 -85.12 63.69 60.43 5.39 96.64 14.65 559.66
TAX 3.15 9.66 -67.39 18.48 16.50 12.00 28.76 2.57 1019.07
Deferred Tax 1.65 3.67 -55.04 7.24 6.41 12.95 13.09 0.77 1600.00
PAT 2.20 26.29 -91.63 45.21 43.93 2.91 67.88 12.08 461.92
Equity 125.89 125.89 0.00 125.89 125.89 0.00 125.89 125.89 0.00
PBIDTM(%) 12.28 18.42 -33.36 16.51 16.23 1.74 17.67 18.39 -3.91
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..